Comparison of the effectiveness between a single low dose and fractionated doses of radioiodine in ablation of post-operative thyroid remnants

Japanese Journal of Clinical Oncology

Volumn 34, Issue 8, 2004, Pages 469-471

  Hung, Guang Uei ^a   Tu, Shih Te ^a   Wu, Iuan Sheng ^a   Yang, Kwang Tao ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Postoperative ablation; Radioiodine therapy; Thyroid carcinoma; Thyroid stunning

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TAIWAN; THYROID CARCINOMA; THYROIDECTOMY; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; THYROID TUMOR;

ADULT; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 7944221600     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh081     Document Type: Article

References (16)

1. Shlossberg AH, Jacobson JC, Ibbertson HK. Serum thyroglobulin in the diagnosis and management of thyroid carcinoma. Clin Endocrinol 1979;10:17-27.
2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994;97:418-28.
3. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: A retrospective review of 1599 patients. J Clin Endocrinol Metal 1992;75:714-20.
4. Sherman SI, Tielens ET, Sostre S, Wharam MD Jr, Ladenson PW. Clinical utility of post-treatment radioiodine scans in the management of patients with thyroid carcinoma. J Clin Endocrinol Metab 1994;78:629-34.
5. 131I ablation for papillary and follicular thyroid carcinoma. Thyroid 1997;7:265-71.
6. Creutzig H. High or low dose radioiodine ablation of thyroid remnants? Eur J Nucl Med 1987;12:500-2.
7. Siddiqui AR, Edmondson J, Wellman HN, Lingeman RE, Park HM, Johnston CC, et al. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma. Clin Nucl Med 1981;6:158-61.
8. Snyder J, Gorman C, Scanlon P. Thyroid remnant ablation: Questionable pursuit of an ill-defined goal. J Nucl Med 1983;24:659-65.
9. 131I dose in differentiated thyroid cancer. Clin Endocrinol 2000;52:765-73.
10. Beierwaltes WH, Rabbani R, Dmuchowski C, Lloyd RV, Eyre P, Mallette S. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: Experience at University of Michigan. J Nucl Med 1984;25:1287-93.
11. Karam M, Gianoukakis A, Feustel PJ, Cheema A, Postal ES, Cooper JA. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nucl Med Commun 2003;24:489-95.
12. Arad E, Flannery K, Wilson GA, O'Mara RE. Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants. Clin Nucl Med 1990;15:676-7.
13. 131I for thyroid remnant ablation after surgery for thyroid cancer. In: Freeman LM, editor. Nuclear Medicine Annual. New York: Raven 1993;223-32.
14. Dow KH, Ferrell BR, Anello C. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997;7:613-9.
15. Brenner W. Is thyroid stunning a real phenomenon or just fiction? J Nucl Med 2002;43:835-6.
16. Park HM, Perkins OW, Edmondson JW, Schnute RB, Manatunga A. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid 1994;4:49-54.